Johnson John Paul 4
4 · Evolent Health, Inc. · Filed Mar 4, 2022
Insider Transaction Report
Form 4
Johnson John Paul
Chief Financial Officer
Transactions
- Tax Payment
Class A Common Stock
2022-03-02$27.54/sh−9,020$248,411→ 219,107 total - Exercise/Conversion
Class A Common Stock
2022-03-02+71,716→ 228,127 total - Tax Payment
Class A Common Stock
2022-03-03$27.54/sh−32,344$890,754→ 186,763 total - Exercise/Conversion
Leveraged Restricted Stock Unit
2022-03-02−71,716→ 0 totalExercise: $0.00→ Class A Common Stock (71,716 underlying)
Footnotes (6)
- [F1]Represents the vesting of the leveraged stock units granted to Mr. Johnson on March 1, 2019, based on the cumulative performance of the Issuer's Class A Common Stock.
- [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F3]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.
- [F4]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of leveraged stock units.
- [F5]Leveraged Stock Units vested on March 2, 2022.
- [F6]The Leveraged Stock Units do not expire.